News Release

Drug shortages prior to and during the COVID-19 pandemic

JAMA Network Open

Peer-Reviewed Publication

JAMA Network

About The Study: Supply chain issues associated with drug shortages increased at the beginning of the COVID-19 pandemic according to the results of this national cross-sectional study. Ongoing policy work is needed to protect U.S. drug supplies from future shocks and to prioritize clinically valuable drugs at greatest shortage risk. 

Authors: Katie J. Suda, Pharm.D., M.S., of the University of Pittsburgh School of Medicine, is the corresponding author. 

To access the embargoed study: Visit our For The Media website at this link 


Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.